February 8, 2023

Caribou have been using the same Arctic calving grounds for more than 3,000 years, according to a new study by the University of Cincinnati. Female caribou shed their antlers within days of giving birth, leaving behind a record of their annual travels across Alaska and Canada’s Yukon that persists on the cold tundra for hundreds or even thousands of years.

September 23, 2022

The University of Cincinnati celebrated the grand opening of its Digital Futures building, a facility for interdisciplinary research, on Friday in the Cincinnati Innovation District.

September 19, 2023

Financial literacy is imperative to improving financial decision making and increasing financial empowerment, University of Cincinnati researchers said, and they’ve developed a scale specifically to measure literacy in the cryptoeconomics sector.

May 16, 2024

UC Vice President for Research Patrick Limbach is a key figure in the National Academies’ massive undertaking to sequence RNA in the next 15 years.

May 21, 2024

In 2019, Munir Nazzal joined the University of Cincinnati College of Engineering and Applied Science as a professor in the Department of Civil and Architectural Engineering and Construction Management. Throughout his time at UC, he has received various accolades for his advancements in transportation research, including the UC George Rieveschl Jr. Award for Distinguished Scientific Research for 2024.

June 7, 2024

Three University of Cincinnati professors were named to the 2023 class of American Association for the Advancement of Science Fellows, a distinguished lifetime honor within the scientific community. From UC's College of Arts and Sciences, Carlton Brett, a professor in the department of geosciences, and George Uetz, a biological sciences professor, were honored. Dionysios Dionysiou, a professor of environmental engineering in the College of Engineering and Applied Science, was honored posthumously.

March 24, 2022

The University of Cincinnati is enrolling patients for a new clinical trial testing a two-pronged immunotherapy approach to treat glioblastomas, deadly brain tumors.

February 2, 2022

The University of Cincinnati's Chad Zender is leading a clinical trial studying if using a combination of Cesium-131 radioactive seeds and immunotherapy can be more effective and provide better quality of life than current treatments for patients with recurrent head and neck cancer.

May 26, 2023

University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology (ASCO) annual meeting 2023, held in Chicago June 2-6.

September 23, 2022

The University of Cincinnati's Pankaj Desai, PhD, has received a $1.19 million grant from the National Institutes of Health/National Institute of Neurological Disorders and Stroke to continue research into the use of a drug called letrozole to treat glioblastomas, the most deadly form of brain tumors.